PPARA and fatty liver disease: Hepatocyte-specific knockdown of PPARα leads to hepatic steatosis by impairing hepatic and whole-body fatty acid homeostasis and increasing hepatic and plasma triglyceride, free fatty acid, and cholesterol levels [32].